We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
-$290K
Cap. Flow
-$14M
Cap. Flow %
-5.35%
Top 10 Hldgs %
74.48%
Holding
143
New
12
Increased
13
Reduced
10
Closed
30
Avg Time Held
1.4 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
CLOZ icon
Panagram BBB-B CLO ETF
CLOZ
+$15.7M
2
ICLO icon
Invesco AAA CLO Floating Rate Note ETF
ICLO
+$5.87M
3
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$3.12M
4
SNY icon
Sanofi
SNY
+$2.3M
5
CLOX icon
Panagram AAA CLO ETF
CLOX
+$1.96M

Top Sells

Rank Stock Value
1
MDWT
Midwest Holding Inc. Common Stock
MDWT
+$10.2M
2
MITAW icon
Coliseum Acquisition Corp. Warrant
MITAW
+$5.69M
3
FBRT icon
Franklin BSP Realty Trust
FBRT
+$4.34M
4
CLMT icon
Calumet Specialty Products
CLMT
+$4.07M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$3.82M

Sector Composition

Rank Sector Weight
1 Materials 30.32%
2 Healthcare 27.8%
3 Miscellaneous 13.82%
4 Financials 10.28%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AB icon
26
AllianceBernstein
AB
$3.19B
$1.52M 0.58%
49,000
-500
-1% -$14.7K
2021 Q4
8 quarters
RHP icon
27
Ryman Hospitality Properties
RHP
$8.68B
$1.32M 0.5%
12,000
– –
2021 Q4
8 quarters
VRTX icon
28
Vertex Pharmaceuticals
VRTX
$127B
$1.22M 0.47%
3,000
– –
2021 Q4
8 quarters
PTGX icon
29
Protagonist Therapeutics
PTGX
$8.35B
$1.2M 0.46%
52,368
– –
2023 Q3
1 quarter
XENE icon
30
Xenon Pharmaceuticals
XENE
$3.25B
$1.1M 0.42%
23,866
– –
2021 Q4
8 quarters
MDLZ icon
31
Mondelez International
MDLZ
$81.4B
$1.01M 0.39%
14,000
– –
2021 Q4
8 quarters
ABEO icon
32
Abeona Therapeutics
ABEO
$252M
$993K 0.38%
198,300
+38,300
+24% +$168K
2022 Q4
4 quarters
XERS icon
33
Xeris Biopharma Holdings
XERS
$1.84B
$912K 0.35%
+387,910
New +$716K
2023 Q4
0 quarters
ABBV icon
34
AbbVie
ABBV
$504B
$781K 0.3%
5,037
– –
2021 Q4
8 quarters
EOLS icon
35
Evolus
EOLS
$470M
$769K 0.29%
73,066
+5,000
+7% +$44.7K
2023 Q1
3 quarters
DD icon
36
DuPont de Nemours
DD
$17.6B
$764K 0.29%
7,911
– –
2021 Q4
8 quarters
KMB icon
37
Kimberly-Clark
KMB
$34.8B
$729K 0.28%
6,000
– –
2021 Q4
8 quarters
VRNA
38
DELISTED
Verona Pharma
VRNA
$650K 0.25%
+32,672
New +$482K
2023 Q4
0 quarters
SYRS icon
39
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$623K 0.24%
79,927
-26,048
-25% -$89.2K
2023 Q2
2 quarters
DOW icon
40
Dow Inc
DOW
$21.5B
$611K 0.23%
11,136
– –
2021 Q4
8 quarters
MSFT icon
41
Microsoft
MSFT
$3.91T
$602K 0.23%
1,600
– –
2021 Q4
8 quarters
CTVA icon
42
Corteva
CTVA
$8.52B
$554K 0.21%
11,563
– –
2021 Q4
8 quarters
CNQ icon
43
Canadian Natural Resources
CNQ
$111B
$550K 0.21%
16,800
– –
2021 Q4
8 quarters
MCRB icon
44
Seres Therapeutics
MCRB
$25.1M
$519K 0.2%
18,537
+15,037
+430% +$395K
2022 Q3
5 quarters
BBIO icon
45
BridgeBio Pharma
BBIO
$12.9B
$484K 0.19%
12,000
+3,000
+33% +$90.1K
2023 Q3
1 quarter
AAPL icon
46
Apple
AAPL
$4.99T
$480K 0.18%
2,494
– –
2021 Q4
8 quarters
KO icon
47
Coca-Cola
KO
$400B
$448K 0.17%
7,600
– –
2021 Q4
8 quarters
ROIV icon
48
Roivant Sciences
ROIV
$24.1B
$418K 0.16%
+37,200
New +$363K
2023 Q4
0 quarters
XOMA icon
49
DELISTED
Xoma
XOMA
$365K 0.14%
19,722
– –
2022 Q4
4 quarters
IBM icon
50
IBM
IBM
$218B
$350K 0.13%
2,142
– –
2023 Q1
3 quarters
1
2
3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q4 2023 Portfolio in Review

As of Q4 2023, David M. Knott Jr held 143 positions worth $262M, down 0.11% from $262M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

David M. Knott Jr withdrew a net $14M in Q4 2023, closing 30 positions and reducing 10 holdings. Its most notable exit was Midwest Holding Inc. Common Stock, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, down from 35% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, David M. Knott Jr opened a new position in Sanofi worth $2.34M.

  • David M. Knott Jr's largest Q4 2023 buy was Sanofi: 47,000 shares worth $2.34M.
  • David M. Knott Jr added most to Panagram BBB-B CLO ETF in Q4 2023, an estimated $15.7M increase.
  • David M. Knott Jr's biggest Q4 2023 reduction was Calumet Specialty Products, cutting an estimated $4.07M.
  • David M. Knott Jr fully exited Midwest Holding Inc. Common Stock in Q4 2023, selling an estimated $10.2M.
  • David M. Knott Jr's ten largest holdings make up 74% of its $262M portfolio in Q4 2023.
  • David M. Knott Jr opened 12 new positions and closed 30 in Q4 2023.
  • David M. Knott Jr's portfolio value fell 0.11% quarter-over-quarter to $262M.

Based on David M. Knott Jr's 13F filing for Q4 2023, filed 13 Feb 2024.